0001193125-22-104068.txt : 20220513 0001193125-22-104068.hdr.sgml : 20220513 20220413135803 ACCESSION NUMBER: 0001193125-22-104068 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc. CENTRAL INDEX KEY: 0001907685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 617.871.2101 EXT 313 MAIL ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 CORRESP 1 filename1.htm CORRESP

Comera Life Sciences Holdings, Inc.

12 Gill Street

Suite 4650

Woburn, Massachusetts 01801

Tel: (617) 871-2101

April 13, 2022

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Alan Campbell and Celeste Murphy

 

Re:

Comera Life Sciences Holdings, Inc.

    

Registration Statement on Form S-4

    

File No. 333-263377

Dear Mr. Campbell and Ms. Murphy

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the registrant, Comera Life Sciences Holdings, Inc. hereby requests acceleration of effectiveness of the above-referenced Registration Statement so that it will become effective at 9:00 a.m. ET on Thursday, April 14, 2022, or as soon as practicable thereafter.

Very truly yours,

COMERA LIFE SCIENCES HOLDINGS, INC.

/s/ Jeffrey S. Hackman

Jeffrey S. Hackman

Chief Executive Officer

 

cc:

Loeb & Loeb LLP

  •  

Mitchell S. Nussbaum, Esq.

  •  

Janeane R. Ferrari, Esq.